147In the second place, the applicant claims that it follows from paragraph 120 of the judgment of 11 May 2017, Deza v ECHA (T‑115/15, EU:T:2017:329), that ECHA may draw up its own criteria for the identification of a substance as an endocrine disruptor within the meaning of Article 57(f) of Regulation No 1907/2006. However, ECHA has not, to date, produced any guidance on the correct way of identifying endocrine disruptors within the framework of Regulation No 1907/2006 in a systematic and foreseeable manner. In other words, ECHA has not adopted ‘its own criteria’ for the identification of endocrine disruptors under Article 57(f) of Regulation No 1907/2006. Since ECHA has not established a transparent and rigorous methodology for the evaluation of bisphenol A in particular, it was impossible for the applicant to foresee how ECHA would apply Article 57(f) of Regulation No 1907/2006 to its situation.